Literature DB >> 30808455

Rapid direct drug susceptibility testing of Mycobacterium tuberculosis based on culture droplet digital polymerase chain reaction.

J Luo1, M Luo2, J Li3, J Yu3, H Yang3, X Yi2, Y Chen2, H Wei3.   

Abstract

SETTING: Early diagnosis and drug susceptibility testing are important for anti-tuberculosis treatment.
OBJECTIVE: To develop a rapid method for detecting Mycobacterium tuberculosis and drug susceptibility based on culture and droplet digital polymerase chain reaction (ddPCR).
DESIGN: M. tuberculosis in 102 sputum samples was detected using ddPCR, Xpert, quantitative PCR (qPCR) and MGIT™ 960™. The susceptibility of ddPCR-positive samples to rifampicin (RMP), isoniazid (INH) and streptomycin (SM) was tested by measuring changes in DNA quantity over 4 days of culture. For comparison, susceptibility of MGIT 960-positive samples was tested using the standard agar proportion method.
RESULTS: The sensitivity and specificity of M. tuberculosis detection using ddPCR and MGIT 960 were respectively 95.7% (95%CI 80.0-99.2) and 88.9% (95%CI 76.7-95.4). Compared with agar proportion, the susceptibility of 44 specimens positive on culture-ddPCR showed sensitivity and specificity for RMP, INH and SM of respectively 83.3% (95%CI 50.9-97.1) and 90.6% (95%CI 73.8-97.6); 79.0% (95%CI 53.9-93.0) and 92% (95%CI 72.5-98.6); 94.1% (95%CI 69.2-99.7) and 92.6% (95%CI 74.3-98.7).
CONCLUSION: Culture ddPCR could detect M. tuberculosis within 5 h and drug susceptibility within 4 days directly from sputum, which would greatly reduce the laboratory time needed for tuberculosis diagnosis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30808455     DOI: 10.5588/ijtld.18.0182

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  5 in total

Review 1.  Improved Conventional and New Approaches in the Diagnosis of Tuberculosis.

Authors:  Baoyu Dong; Zhiqun He; Yuqing Li; Xinyue Xu; Chuan Wang; Jumei Zeng
Journal:  Front Microbiol       Date:  2022-05-31       Impact factor: 6.064

2.  Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.

Authors:  Adrienne E Shapiro; Jennifer M Ross; Mandy Yao; Ian Schiller; Mikashmi Kohli; Nandini Dendukuri; Karen R Steingart; David J Horne
Journal:  Cochrane Database Syst Rev       Date:  2021-03-23

3.  Development of a Droplet Digital Polymerase Chain Reaction for Sensitive Detection of Pneumocystis jirovecii in Respiratory Tract Specimens.

Authors:  Jie Yi; Nan Wang; Jie Wu; Yueming Tang; Jingjia Zhang; Lingxiang Zhu; Xiao Rui; Yong Guo; Yingchun Xu
Journal:  Front Med (Lausanne)       Date:  2021-12-22

Review 4.  Application of Droplet Digital PCR to Detection of Mycobacterium tuberculosis and Mycobacterium leprae Infections: A Narrative Review.

Authors:  Yuxin Fan; Jingjing Chen; Meixiao Liu; Xin Xu; Yu Zhang; Peng Yue; Wenjing Cao; Zhenhua Ji; Xuan Su; Shiyuan Wen; Jing Kong; Guozhong Zhou; Bingxue Li; Yan Dong; Aihua Liu; Fukai Bao
Journal:  Infect Drug Resist       Date:  2022-03-15       Impact factor: 4.003

5.  Development and Evaluation of a Single Dye Duplex Droplet Digital PCR Assay for the Rapid Detection and Quantification of Mycobacterium tuberculosis.

Authors:  Raphael Nyaruaba; Jin Xiong; Caroline Mwaliko; Nuo Wang; Belindah J Kibii; Junping Yu; Hongping Wei
Journal:  Microorganisms       Date:  2020-05-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.